Get to know your Medicare plan or explore plans with added benefits and services for you. Individuals and families Get helpful guidance to understand your health plan or find quality coverage for you and your family. Medical providers Join the Aetna network, so together we can give patients acce...
Scope of Policy This Clinical Policy Bulletin addresses botulinum toxin for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of botulinum toxin (Botox [onabotulinumtoxinA]; Daxxify [daxibotulinumtoxinA-lanm], Dysport [abobo...
This Clinical Policy Bulletin addresses infliximab for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of an infliximab product (Avsola, Inflectra, Remicade, or Renflexis) is required of all Aetna participating providers and ...
For Medicare criteria, see Medicare Part B Criteria. Note: Requires Precertification: Precertification of certolizumab pegol (Cimzia) is required of all Aetna participating providers and members in applicable plan designs. For precertification, call (866) 752-7021 or fax (888) 267-3277. For State...
For Medicare criteria, see Medicare Part B Criteria.Note: Requires Precertification:Precertification of omalizumab (Xolair) is required of all Aetna participating providers and members in applicable plan designs. For precertification of omalizumab call (866) 752-7021 or fax (888) 267-3277. For ...
This Clinical Policy Bulletin addresses vascular endothelial growth factor inhibitors for ocular indications for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of aflibercept [(Eylea), (Eylea HD)], aflibercept-jbvf (Yesafili...
For Medicare criteria on intravenous Cosentyx, see Medicare Part B Criteria. Note: Precertification of intravenous (IV) secukinumab (IV Cosentyx only) is required of all Aetna participating providers and members in applicable plan designs. For precertification of IV Cosentyx, call (866) 752-7021 ...
This Clinical Policy Bulletin addresses pembrolizumab (Keytruda) for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of pembrolizumab (Keytruda) is required of all Aetna participating providers and members in applicable plan desi...
This Clinical Policy Bulletin addresses ipilimumab (Yervoy) for commercial medical plans. For Medicare criteria, see Medicare Part B Criteria.Note: Requires Precertification:Precertification of ipilimumab (Yervoy) is required of all Aetna participating providers and members in applicable plan designs. For...
For Medicare criteria, see Medicare Part B Criteria. Note: Requires Precertification: Precertification of nivolumab (Opdivo), nivolumab and hyaluronidase-nvhy (Opdivo Qvantig), and nivolumab and relatlimab-rmbw (Opdualag) is required of all Aetna participating providers and members in applicable ...